glucagon has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, NT; Andersen, R; Andersen, SK; Brix-Christensen, V; Dyhr, T; Larsson, A; Mengel, A; Schmitz, O; Tønnesen, E; Ørskov, H | 1 |
| Baue, AE; Durham, RM; Mazuski, JE | 1 |
1 review(s) available for glucagon and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Clinical trials of new and novel therapeutic agents.
Topics: Antithrombin III; Clinical Trials as Topic; Combined Modality Therapy; Critical Care; Glucagon; Growth Substances; Humans; Inflammation Mediators; Ketoconazole; Life Support Care; Multiple Organ Failure; Systemic Inflammatory Response Syndrome; Treatment Outcome | 1996 |
1 other study(ies) available for glucagon and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model.
Topics: Acute Disease; Animals; Blood Glucose; Blood Pressure; Endotoxins; Fatty Acids, Nonesterified; Female; Glucagon; Hyperinsulinism; Interleukin-6; Neutrophils; Swine; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2004 |